Arama Sonuçlarını Sınırlandır
by
Çetinkaya, Melisa, author.
Format:
Alıntı:
flavonoids in cancer therapeutics, which are secondary metabolites of plants mainly responsible for plants
by
Kuş, Muammer Emre, author.
Format:
Alıntı:
cancer patients, which are open to the public through The Cancer Genome Atlas initiative, especially for
by
Mohammed, Abdurehman Eshete, author.
Format:
Alıntı:
the cause of more than half a million females death each year. The primary cause of cancer patients
by
Yücel, Müge, author.
Format:
Alıntı:
probe with principal component analysis proves the separation of healthy individuals from patients with
by
Terlemez, Gamze, author.
Format:
Alıntı:
cancer and other systemic disease risks. IBD consists of two groups as Ulcerative colitis (UC) and Crohn
by
Özdemir, Sefayi Merve, author.
Format:
Alıntı:
important to improve the survival period of the cancer patients. There are many strategies for synthesis of
by
Bilgen, Müge, author.
Format:
Alıntı:
world. The leading cause of death for cancer patients is tumor metastasis. Cancer cells can extravasate
by
Gürler, Sevim Beyza, author.
Format:
Alıntı:
thatluteolin has anti-cancer and anti-tumor effects on wide range cancer types including breast, colon, lung
by
Elvan, Menşure, author.
Format:
Alıntı:
physically handicapped people who are inadequate in oral hygiene and after chemotherapy of cancer patients
by
Şahi, Ece, author.
Format:
Alıntı:
associated with better survival of triple negative breast cancer patients. However, there is not any
by
Delman, Murat, author.
Format:
Alıntı:
treatment of HCC. One of the most important target in cancer treatment is the epigenetic acetylation of
by
Atahanova, Hurshida, author.
Format:
Alıntı:
overexpressed in many cancer types. Lately, polymeric prodrugs developed which contain bioactive unit and have
Eylem Seç